In this presentation from the 14th Annual World CB & CDx Summit, hear our expert discuss the unresolved questions in regards to multiple myeloma and its associated resistance mechanisms and how they impact therapeutic treatments over time, and how single cell multiomics can be leveraged to address these questions.